Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines

被引:12
|
作者
Gogusev, J
Telvi, L
Nezelof, C
机构
[1] Hop Necker Enfants Malad, INSERM U507, F-75015 Paris, France
[2] Hop St Vincent de Paul, Grp Pathol Pediat, Lab Cytogenet, F-75674 Paris, France
关键词
D O I
10.1016/S0165-4608(02)00589-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic large cell lymphomas (ALCL) in children represent a heterogeneous group of neoplasms with regard to the cell lineages involved. The chromosomal 5q35 breakpoint (bp) and the expression of the NPM/ALK fusion gene are the most remarkable molecular cytogenetic features of these malignancies. To identify new locations of ALCL-related oncogenes, comparative genomic hybridization (CGH) was applied to three ALCL cell lines (SU-DHL-1, Karpas 299, and DEL) exhibiting the 5q35 bp and expressing the NPM/ALK transcript. The CGH profiles were compared with those obtained with DNA from U937, HL-60 cells, and altered lymph nodes from two children with ALCL. Significant DNA copy number gains and/or losses were observed on several chromosomes in all ALCL cell lines. Distinct amplicons were detected on 1q21similar toq44 (DEL), 7q12 (SU-DHL-1), and 1q12similar toq22 (Karpas 299) regions. The NPM/ALK fusion gene was confirmed by fluorescence in situ hybridization (FISH) analysis in more than 80% of interphase nuclei and metaphase spreads. Enhanced expression of TGF-beta2 and c-MET candidate genes located at the amplified regions was revealed in DEL and SU-DHL1 cell lines by Northern blot analysis. These findings delineate chromosomal imbalances in ALCL-derived cell lines in parallel with high level of amplification covering target DNA sequences, which could play a role in ALCL pathogenesis. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [1] PRIMARY CUTANEOUS ANAPLASTIC CD30+ LARGE CELL LYMPHOMA
    Marrero-Calvo, M. D.
    Rodriguez-Serna, M.
    Castejon-Calvete, P.
    Pelaez-Malagon, S.
    ACTAS DERMO-SIFILIOGRAFICAS, 2007, 98 (03): : 194 - 197
  • [2] Anaplastic large T cell CD30+ lymphoma (ALCL)
    De Pasquale, R
    Torrisi, L
    Gangemi, P
    Micali, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (05) : A96 - A96
  • [3] Challenges in the diagnosis of CD30+ anaplastic large-cell lymphoma
    Dobos, G.
    Battistella, M.
    Jouenne, F.
    Mourah, S.
    Vignon-Pennamen, M. D.
    Ram-Wolff, C.
    Herms, F.
    Er, J. N. Dauendorff
    Rivet, J.
    Cayuela, J. M.
    Bouaziz, J. D.
    Brice, P.
    Lebbe, C.
    Bagot, M.
    de Masson, A.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S24 - S25
  • [4] Activation of the CD30 signaling pathway causes proliferation of cutaneous CD30+ anaplastic large cell lymphoma cell lines.
    Levi, E
    Pfeifer, W
    Petrogiannis-Haliotis, T
    Wang, ZX
    Kadin, ME
    LABORATORY INVESTIGATION, 1999, 79 (01) : 141A - 141A
  • [5] Cytokine expression of CD30+ anaplastic large cell lymphoma cell lines - Comparison of nodal versus cutaneous ALCL
    Pfeifer, W
    Levi, E
    Petrogiannis-Haliotis, T
    Telleman, P
    Wang, ZX
    Kadin, ME
    LABORATORY INVESTIGATION, 1999, 79 (01) : 144A - 144A
  • [6] Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma
    Shehan, JM
    Kalaaji, AN
    Markovic, SN
    Ahmed, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (01) : 103 - 110
  • [7] Spectrum of CD30+ Lymphoid Proliferations in the Eyelid Lymphomatoid Papulosis, Cutaneous Anaplastic Large Cell Lymphoma, and Anaplastic Large Cell Lymphoma
    Sanka, R. Krishna
    Eagle, Ralph C., Jr.
    Wojno, Ted H.
    Neufeld, Kenneth R.
    Grossniklaus, Hans E.
    OPHTHALMOLOGY, 2010, 117 (02) : 343 - 351
  • [8] Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression
    Winhoven, SM
    Murugesan, S
    Coulson, IH
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (03) : 385 - 385
  • [9] CD30+ ANAPLASTIC LARGE-CELL LYMPHOMAS
    KAUDEWITZ, P
    KIND, P
    SANDER, CA
    SEMINARS IN DERMATOLOGY, 1994, 13 (03): : 180 - 186